18
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T10919 |
Cyclophilin inhibitor 1
|
Others | Others |
Cyclophilin inhibitor 1 is an effective and orally bioavailable cyclophilin A inhibitor with a Kd of 5 nM, showing potent anti-HCV activity, and an EC50 for HCV 2a of 98 nM. | |||
T64220 |
Cyclophilin inhibitor 3
|
||
Cyclophilin inhibitor 3 (compound 7c) 是一种 cyclophilin A (CypA) 的有效抑制剂,表现出有效的抗 HCV 作用,其 EC50 值为 4.2 μM。 | |||
T9936 |
ZX-J-19J
N-(2,3-Diphenyl-6-quinoxalinyl)octanamide |
Others | Others |
ZX-J-19J (N-(2,3-Diphenyl-6-quinoxalinyl)octanamide) 是 Cyclophilin J 的抑制剂,对肿瘤细胞生长有显着的抑制作用,与环孢素 A 相当,但比 5-氟尿嘧啶强得多。 | |||
T13171 |
TMN355
2-氯-N-[(9H-芴-9-氨基)羰基]-6-氟苯甲酰胺 |
Others | Others |
TMN355 是一种化学亲环素 A 抑制剂,能够抑制泡沫细胞形成和细胞因子分泌,可用于动脉粥样硬化的研究。 | |||
T18928 |
Brilliant Black BN
亮黑1,E 151 |
Others; Virus Protease | Microbiology/Virology; Others |
Brilliant Black BN (E 151) 是一种偶氮染料和一种食品着色剂。它抑制 EV71 与其细胞脱壳因子亲环蛋白 A 之间的相互作用,是一种很有前途的抗 EV71 感染的抗病毒药物。 | |||
T12226 |
NIM811
SDZ NIM811,(Melle-4)cyclosporin |
Others | Others |
NIM811 is an orally bioavailable dual inhibitor of mitochondrial permeability transition and cyclophilin. | |||
T70811 | CRV431 | ||
CRV431 is a novel Pan-Cyclophilin Inhibitor, potently inhibiting all cyclophilin isoforms tested - A, B, D, and G (IC50 values ranged from 1-7 nM). | |||
T14180 |
Alisporivir
DEB-025,Debio-025 |
Others | Others |
Alisporivir (Debio-025) is a cyclophilin inhibitor molecule.It has potent anti-hepatitis C virus (HCV) activity. | |||
T76228 |
ASP5286
|
||
ASP5286 是一种新型的非免疫 cyclophilin 抑制剂,用于研究 HCV。 | |||
T71997 | CypD-IN-29 | ||
CypD-IN-29 is a non-peptidic inhibitor of cyclophilin D as a neuroprotective agent in Aβ-induced mitochondrial dysfunction. | |||
TP1665 |
Cyclosporin D
|
||
Cyclosporin D is a metabolite of cyclosporin A, an immunosuppressant drug that binds cyclophilin D, inhibiting the phosphatase activity of calcineurin in T cells. | |||
TP1387 |
Cyclosporin A-Derivative 2
|
||
Derivative 2 is A novel Derivative of Cyclosporin A.Cyclosporin A is an immunosuppressant that binds to cyclophilin and inhibits calcineurin. | |||
T36642 | RAS/RAS-RAF-IN-1 | ||
RAS/RAS-RAF-IN-1 is a potent RAS and RAS-RAF inhibitor. RAS/RAS-RAF-IN-1 has a KD of 5.0 μμ-15 μμ for cyclophilin A (CYPA) binding affinity. RAS/RAS-RAF-IN-1 has antitumor activity[1]. RAS/RAS-RAF-IN-1 (compound 89; for 4 hours) has an EC50 of 0.5 μμ-5.0 μμ for BRAF-GTP-KRAS-G12C disruption and has an IC50 of 1.0 μμ-10 μμ for pERK inhibition in H358 cells[1]. [1]. Meizhong Jin, et al. Compounds that participate in cooperative binding and uses thereof. WO2020132597A1. | |||
T63090 | SMCypI C31 | ||
SMCypIC31 是一种非肽类 cyclophilin 抑制剂,能够有效抑制肽基-脯氨酰顺/反异构酶 (PPIase) (IC50: 0.1 μM)。SMCypI C31 可以破坏亲环蛋白 A-NS5A 相互作用。SMCypI C31 具有泛基因型抗 HCV 效果,对基因型 1a,1b,2a,3a 和 5a HCV-SGRs 和嵌合基因型 2a/4a HCV-SGRs 的 EC50 范围为 1.20-7.76 μM。 | |||
T74963 | CypD-IN-3 | ||
CypD-IN-3是一种高效的CypD (亲环蛋白D) 选择性抑制剂,其对CypD的IC50值仅为0.01 μM。该化合物在氧化应激、神经退行性疾病、肝病、衰老、自噬及糖尿病等多种疾病的研究中有潜在应用。 | |||
T74965 | CypE-IN-1 | ||
CypD-IN-1 是一种有效的亚型选择性亲环蛋白 E (CypE) 抑制剂。CypD-IN-1 具有 CypE 亲和力,IC50和 Ki 值分别为 0.013 μM 和 0.072 μM。CypD-IN-1 可用于多种疾病的研究,如氧化应激、神经退行性疾病、肝病、衰老、自噬和糖尿病。 | |||
T74964 | CypD-IN-4 | ||
CypD-IN-4是一种针对亲环蛋白D(CypD)的有效亚型选择性抑制剂,展现出0.057 μM的IC50,表明其对CypD具有高度亲和力。该化合物适用于氧化应激、神经退行性疾病、肝病、衰老、自噬及糖尿病等多种疾病的研究。 | |||
T75131 |
RMC-6291
|
||
RMC-6291 是一种口服有效的KRASG12C(ON)共价抑制剂。RMC-6291 在 KRASG12C(ON) 和亲环蛋白 A (CypA) 之间的肿瘤细胞内形成三复合物。因此,RMC-6291 通过空间阻断RAS 效应子结合来阻止 KRASG12C(ON) 发出信号。RMC-6291 在 KRASG12C 肿瘤模型中对RAS 通路活性产生了深度和持久抑制。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T5S1133 |
Ganoderic acid D
灵芝酸D,灵芝酸 D |
Apoptosis; Sirtuin | Apoptosis; Chromatin/Epigenetic; DNA Damage/DNA Repair |
Ganoderic acid D 是高度氧化的四环三萜,是灵芝的主要活性成分,可诱导 HeLa 人宫颈癌细胞凋亡。它上调 SIRT3的蛋白质表达并通过 SIRT3 诱导脱乙酰化的亲环蛋白 D 。它抑制结肠癌细胞的能量重编程,包括结肠癌细胞中的葡萄糖摄取,乳酸、丙酮酸和乙酰辅酶的产生。 |